Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Gilead stock steadies in Wall Street selloff as Bernstein sticks with $135 target and Florida HIV funding shifts loom

Gilead stock steadies in Wall Street selloff as Bernstein sticks with $135 target and Florida HIV funding shifts loom

Gilead Sciences shares edged down 0.2% to $124.68 in afternoon trade, after swinging between $122.49 and $126.22 earlier. Bernstein SocGen Group held firm on its Outperform rating and $135 price target, pointing to Yeztugo as a major driver for Gilead’s 2026 forecast. The firm also flagged that the market may be underestimating the boost from re-dosing planned for later this year.
Boeing stock price dips despite Ethiopian Dreamliner order as BA heads into earnings spotlight

Boeing stock price dips despite Ethiopian Dreamliner order as BA heads into earnings spotlight

Boeing shares slipped slightly Tuesday after Ethiopian Airlines placed an order for nine 787-9 Dreamliners and finalized the purchase of 11 737 MAX jets, the companies confirmed. The stock traded around $247.13 in the afternoon, down about 0.2%, after fluctuating between $240.08 and $248.43. Ethiopian Airlines Group CEO Mesfin Tasew said, “We will continue to acquire more aircraft and adopt the latest technologies as part of our strategic vision to advance sustainable aviation.”
Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land

Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land

Pfizer shares slipped 0.7% to $25.47 Tuesday afternoon, after GSK and Shionogi announced Pfizer will exit HIV-focused ViiV Healthcare in a $1.9 billion deal. Pfizer is set to get $1.88 billion for its 11.7% stake, with the deal expected to close in Q1 pending regulatory approval. That day, the stock fluctuated between $25.11 and $25.65. ViiV chair David Redfern called the move a way to “simplify the shareholder structure.” Pfizer has also cautioned investors that 2026 could be challenging, as COVID-19 product sales decline, pricing pressures mount, and key patents expire.
Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next

Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next

By 2:48 p.m. EST Tuesday, Verizon Communications Inc shares had risen roughly 0.4% to $39.07, following the closing of its cash acquisition of Frontier Communications Parent, according to an SEC filing. AT&T shares slipped about 0.2%, while T-Mobile US dropped around 0.6%. Frontier shareholders will receive $38.50 per share in cash, the filing stated.
Capital One stock slides nearly 4% as credit-card rate cap deadline weighs on lenders

Capital One stock slides nearly 4% as credit-card rate cap deadline weighs on lenders

Capital One Financial shares dropped 3.7% to $230.18 in Tuesday afternoon trading, underperforming the S&P 500 banks index, which fell 1.2%. Investors are weighing whether the Trump administration will push forward with a proposed one-year, 10% cap on credit-card interest rates after the Jan. 20 deadline, amid doubts about enforcing it without Congress. “For now, it’s an overhang,” Brian Jacobsen, chief economic strategist at Annex Wealth Management, told Reuters. The American Bankers Association warned that up to 159 million cardholders could lose access. Meanwhile, TD Cowen anticipates a “political compromise” involving stripped-down low-rate cards and voluntary “Trump cards” as potential workarounds.
20 January 2026
1 446 447 448 449 450 893
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.